Remdesivir Safety and Efficacy

Allyson van de Pol根據公開資料要求醫院管理局披露資料

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

醫院管理局沒有要求披露的資料。

Dear Hospital Authority,

Please refer to the link below regarding Remdesivir:

https://www.drugoffice.gov.hk/eps/do/en/...

"As part of the conditional approval of registration, Gilead is still required to submit additional safety, efficacy and quality data through on-going clinical studies and post-marketing report to the Drug Office of Department of Health according to the conditions imposed by the Committee. "

Please supply the findings of these ongoing clinical studies and post marketing reports.

Thank you

Yours faithfully,

Allyson van de Pol

Enquiry (Hospital Authority), 醫院管理局

This is to acknowledge receipt of your e-mail message.
 
(The above is generated by an auto-reply programme)
 
 
 
Hospital Authority ([1]www.ha.org.hk)
 
 
=====================================
 
謝謝閣下的電子郵件。
 
(以上為電腦自動發出的訊息)
 
 
 
醫院管理局 ([2]www.ha.org.hk)
 
 
=====================================
 
谢谢阁下的电子邮件。
 
(以上为电脑自动发出的讯息)
 
 
 
医院管理局 ([3]www.ha.org.hk)
 
  ________________________________  

顯示引用部分

References

Visible links
1. file:///tmp/www.ha.org.hk
2. file:///tmp/www.ha.org.hk
3. file:///tmp/www.ha.org.hk

Enquiry (Hospital Authority), 醫院管理局

Dear Mrs Van de Pol,

 

Thank you for your Application for Access to Information dated 22 February
2022.

 

Please be advised that the Hospital Authority does not receive the
findings of the ongoing clinical studies and post-marketing reports from
the pharmaceutical company concerned and hence is not in possession of the
information you requested. According to paragraph 1.14 of the Code on
Access to Information, the Code does not oblige departments to create a
record which does not exist.

 

If you have any questions about this reply, please do not hesitate to
contact me.

 

 

 

Yours sincerely,

Joey Lai

for Access to Information Officer

Hospital Authority Head Office

(Tel.: 2300 6836/2300 6555)

 

顯示引用部分

Dear Enquiry (Hospital Authority),

Thanks very much, however isn't a condition of the use of Remdesivir that these reports and data should be made available, considering that for under 12s it's a EUA drug with no safety or efficacy data?

Yours sincerely,

Allyson van de Pol

Enquiry (Hospital Authority), 醫院管理局

This is to acknowledge receipt of your e-mail message.
 
(The above is generated by an auto-reply programme)
 
 
 
Hospital Authority ([1]www.ha.org.hk)
 
 
=====================================
 
謝謝閣下的電子郵件。
 
(以上為電腦自動發出的訊息)
 
 
 
醫院管理局 ([2]www.ha.org.hk)
 
 
=====================================
 
谢谢阁下的电子邮件。
 
(以上为电脑自动发出的讯息)
 
 
 
医院管理局 ([3]www.ha.org.hk)
 
  ________________________________  

顯示引用部分

References

Visible links
1. file:///tmp/www.ha.org.hk
2. file:///tmp/www.ha.org.hk
3. file:///tmp/www.ha.org.hk

Enquiry (Hospital Authority), 醫院管理局

Dear Mrs Van de Pol,

 

Thank you for your email dated 3 March 2022.

 

Please be advised that the pharmaceutical company concerned is not obliged
to make the information available to the Hospital Authority.  You may
approach the Pharmacy and Poisons Board of Hong Kong if necessary.

 

If you have any questions about this reply, please do not hesitate to
contact me.

 

 

 

Yours sincerely,

Joey Lai

for Access to Information Officer

Hospital Authority Head Office

(Tel.: 2300 6836/2300 6555)

 

顯示引用部分

Dear Enquiry (Hospital Authority),

Thanks- can you please advise how I can contact them?

Yours sincerely,

Allyson van de Pol

Enquiry (Hospital Authority), 醫院管理局

This is to acknowledge receipt of your e-mail message.
 
(The above is generated by an auto-reply programme)
 
 
 
Hospital Authority ([1]www.ha.org.hk)
 
 
=====================================
 
謝謝閣下的電子郵件。
 
(以上為電腦自動發出的訊息)
 
 
 
醫院管理局 ([2]www.ha.org.hk)
 
 
=====================================
 
谢谢阁下的电子邮件。
 
(以上为电脑自动发出的讯息)
 
 
 
医院管理局 ([3]www.ha.org.hk)
 
  ________________________________  

顯示引用部分

References

Visible links
1. file:///tmp/www.ha.org.hk
2. file:///tmp/www.ha.org.hk
3. file:///tmp/www.ha.org.hk

Enquiry (Hospital Authority), 醫院管理局

Dear Mrs Van de Pol,

 

Thank you for your email dated 12 March 2022.

 

Contact details of the Pharmacy and Poisons Board of Hong Kong can be
accessed via:

 

[1]https://www.ppbhk.org.hk/eng/contact/con...

 

 

 

Yours sincerely,

Joey Lai

for Access to Information Officer

Hospital Authority Head Office

(Tel.: 2300 6836/2300 6555)

 

顯示引用部分

Dear Enquiry (Hospital Authority),

Thnank you!

Yours sincerely,

Allyson van de Pol

Enquiry (Hospital Authority), 醫院管理局

This is to acknowledge receipt of your e-mail message.
 
(The above is generated by an auto-reply programme)
 
 
 
Hospital Authority ([1]www.ha.org.hk)
 
 
=====================================
 
謝謝閣下的電子郵件。
 
(以上為電腦自動發出的訊息)
 
 
 
醫院管理局 ([2]www.ha.org.hk)
 
 
=====================================
 
谢谢阁下的电子邮件。
 
(以上为电脑自动发出的讯息)
 
 
 
医院管理局 ([3]www.ha.org.hk)
 
  ________________________________  

顯示引用部分

References

Visible links
1. file:///tmp/www.ha.org.hk
2. file:///tmp/www.ha.org.hk
3. file:///tmp/www.ha.org.hk